A two-day “Invention Analysis and Claiming” seminar is being offered this May in New York (May 12-13), Chicago (May 16-17) and Santa Clara (May 19-20). The program is based on the book “Invention Analysis and Claiming: A Patent Lawyer’s Guide” published by the ABA. The program presents strategic approaches for analyzing inventions and claiming them […]
HCBC and BioStart are seeking early stage, technology focused entrepreneurs who are in need of assistance in building their business and their business plan. They are offering a 10-week program called Kauffman FastTrac® TechVentureâ„¢. This is the second offering of this program locally. They offered this program in the Fall of 2010, and successfully graduated […]
After filing a series of five continuation-in-part (“CIP”) applications, which added new matter , a patent finally issued containing claims covering Abbott’s antibody. Centocor then relied on the added material as evidence of written description to support later asserted claims. The Federal Circuit poo-poohed the idea saying that PTO guidelines prevent claiming a high affinity, […]
Article 229-C of the Brazilian IP Law establishes the need of a “prior approval” by the Agência Nacional de Vigilância Sanitária – ANVISA (the Brazilian regulatory agency responsible for the approval of drugs) – for the issuance of a patent in the pharmaceutical area. This requirement was introduced by the Brazilian Law No. 10.196 of […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
